middle.news
LTR Pharma Accelerates US Entry with ROXUS Launch and FDA Green Light for SPONTAN
6:16am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
LTR Pharma Accelerates US Entry with ROXUS Launch and FDA Green Light for SPONTAN
6:16am on Monday 2nd of June, 2025 AEST
Key Points
FDA pre-IND meeting confirms clear regulatory pathway for SPONTAN
SPONTAN achieves 470% faster absorption than oral ED tablets, winning top scientific award
ROXUS nasal spray launched to target US personalised healthcare market
Australian distribution expands via pharmacy and telehealth partnerships
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
LTP
OPEN ARTICLE